ORLANDO, Fla.—Variant hemoglobin phenotypes, including sickle cell trait and hemoglobin C trait, may be associated with resistance to treatment with erythropoiesis-stimulating agents (ESAs) among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback